Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. CellaVision AB (publ)
  6. Summary
    CEVI   SE0000683484

CELLAVISION AB (PUBL)

(CEVI)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Stockholm
12/03/2021 12/06/2021 12/07/2021 12/08/2021 12/09/2021 Date
321.8(c) 315.4(c) 320(c) 316(c) 317.2 Last
11 384 9 705 20 954 21 304 3 337 Volume
-2.19% -1.99% +1.46% -1.25% +0.38% Change
More quotes
Estimated financial data (e)
Sales 2021 563 M 62,2 M 62,2 M
Net income 2021 121 M 13,4 M 13,4 M
Net cash position 2021 76,4 M 8,45 M 8,45 M
P/E ratio 2021 62,1x
Yield 2021 0,59%
Sales 2022 658 M 72,8 M 72,8 M
Net income 2022 154 M 17,1 M 17,1 M
Net cash position 2022 169 M 18,7 M 18,7 M
P/E ratio 2022 48,9x
Yield 2022 0,74%
Capitalization 7 537 M 833 M 834 M
EV / Sales 2021 13,3x
EV / Sales 2022 11,2x
Nbr of Employees -
Free-Float 64,5%
More Financials
Company
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision ABÔÇÖs product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education.... 
More about the company
Ratings of CellaVision AB (publ)
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about CELLAVISION AB (PUBL)
12/07CELLAVISION : Happy Holidays 2021 from CellaVision!
PU
10/22CELLAVISION : Strong sales and earnings growth in line with improving market conditions
AQ
10/22CellaVision AB Reports Earnings Results for the Third Quarter and Nine Months Ended Sep..
CI
10/08CELLAVISION PRESENTS THE INTERIM REP : 00 cest
AQ
07/20CELLAVISION : Increasing activity levels and double-digit growth with maintained strong pr..
AQ
07/05CELLAVISION PRESENTS THE INTERIM REP : 00 cest
AQ
04/30CELLAVISION AB (PUBL) : Ex-dividend day for final dividend
FA
04/29CELLAVISION : Bulletin from the annual general meeting of CellaVision AB (publ)
AQ
04/29CellaVision AB Approves Dividend, Payable on 6 May 2021
CI
04/29CellaVision AB Elects Mikael Worning as Chairman of the Board of Directors
CI
04/28CELLAVISION AB : Strong profitability and positive development in Europe
AQ
04/28Sören Mellstig to Leave Cellavision AB as Chairman
CI
04/20CELLAVISION : completes the acquisition of exclusive rights to novel microscopy technology
AQ
04/20CellaVision AB Completes the Acquisition of Exclusive Rights to Novel Microscopy Techno..
CI
04/20CELLAVISION AB (OM : CEVI) completed the acquisition of Clearbridge BioPhotonics, Pte Ltd ..
CI
More news
News in other languages on CELLAVISION AB (PUBL)
04/29CellaVision AB (publ) approuve un dividende, payable le 6 mai 2021
02/04Cellavision AB (Publ) propose un dividende pour 2020
2020AVIS D'ANALYSTES DU JOUR : EasyJet, Givaudan, Lisi, Quadient, Sodexo, Sopra, STMicroelectr..
More news
Chart CELLAVISION AB (PUBL)
Duration : Period :
CellaVision AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CELLAVISION AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 2
Last Close Price 316,00 SEK
Average target price 337,50 SEK
Spread / Average Target 6,80%
EPS Revisions
Managers and Directors
Simon Ostergaard President & Chief Executive Officer
Magnus Blixt Chief Financial Officer
Mikael Worning Chairman
Adam Morell Vice President-Engineering
Anna Yvonne Monica Malm Bernsten Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CELLAVISION AB (PUBL)2.93%833
SARTORIUS AG42.61%41 051
BIOTAGE AB (PUBL)77.99%1 847
REVENIO GROUP OYJ11.03%1 668
VAREX IMAGING CORPORATION74.22%1 146
908 DEVICES INC.-52.70%783